Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


Home > Issues > Prescription drugs
 

Prescription drugs

Change Text Size:   Smaller Text Size   Larger Text Size   Default Text Size    

The following is a list of briefings, documents, and publications that have been ranked by the Alliance for Health Reform in order of relevance, 10 being "Exclusively Related" to the issue, to 5 being "Somewhat Related" to the issue. Webcasts, transcripts and resource materials can be downloaded for each briefing listed.
 
RankTypeDescription
10Briefing  Pharmaceutical Policy and Pricing: Are Other Countries Getting Greater Value?, 11/7/2011
Spending on prescription drugs in the U.S. rose at a faster clip in 2009 than spending for hospital and physician care, a trend that is expected to continue through 2020. Thus, federal and state budget cutters – as well as private health plans and hospitals – have a keen interest in restraining drug costs. The desire to get a handle on drug spending is a focus in other countries as well. What are some strategies used in other countries to control pharmaceutical spending? How are value-based models being used by insurers and others to influence pharmaceutical utilization and health outcomes? How do the public and private sectors in the United States seek to contain pharmaceutical spending? To address these and related questions, the Alliance for Health Reform and The Commonwealth Fund are sponsoring a November 7 luncheon briefing. 
10Briefing  Reviewing Prescription Drug Coverage: Policies and Practices Across Several Health Systems, 6/23/2006
The Medicare prescription drug program offers coverage for prescription drugs through competing private plans, within a framework established by law and through rules established by the Centers for Medicare and Medicaid Services. In contrast, other countries, including Australia, the UK, and Canada, provide similar prescription drug programs, but within different regulatory structures. How do these countries decide which drugs will be approved and included in their prescription drug programs for the elderly and disabled?  
10Document  Spatz Presentation, 11/7/2011
 (PowerPoint)
10Document  Hess Presentation, 11/7/2011
 (PowerPoint)
10Document  Dillon Presentation, 11/7/2011
 (PowerPoint)
10Document  Harousseau Presentation, 11/7/2011
 (PowerPoint)
10Other PublicationSourcebook 2004 - Chapter 6: Prescription Drugs, 9/1/2004
This chapter from the Alliance sourcebook, “Covering Health Issues, 2004” presents key facts, background, story ideas, experts and websites on the subject of prescription drugs. (Adobe Acrobat PDF)
10Offsite Document  Seniors Feeling the Squeeze: Rising Drug Prices and the Part D Program, 3/17/2010
 - Source: American Enterprise Institute (Unknown File Type)
10Offsite Document  U.S. drug spending slows; hits $307 bln in 2010: report, 4/19/2011
 - Source: Reuters (Unknown File Type)
10Offsite Document  At Pitney Bowes, Value-Based Insurance Design Cut Copayments and Increased Drug Adherence, 11/2/2010
 - Source: The Commonwealth Fund (Unknown File Type)
10Offsite Document  Comparative Effectiveness Review Within the U.K.’s National Institute for Health and Clinical Experience, 7/1/2009
 - Source: The Commonwealth Fund Adobe Acrobat PDF
10Offsite Document  Drug program saves state millions – but more can be done, 11/1/2011
 - Source: The Olympian (Unknown File Type)
10Offsite Document  Ending drug companies’ pay-for-delay deals, 10/24/2011
 - Source: The Washington Post (Unknown File Type)
10Offsite Document  Descriptions of Health Care Systems: England, France, and Germany, 12/31/2011
 - Source: The Commonwealth Fund (Unknown File Type)
10Offsite Document  The World Medicines Situation 2011, 1/1/2011
 - Source: World Health Organization (Unknown File Type)
10Offsite Document  US Pharmaceutical Policy In A Global Marketplace, 12/16/2008
 - Source: Health Affairs Adobe Acrobat PDF
10Offsite Document  Projecting future drug expenditures – 2009, 2/1/2009
 - Source: American Journal of Health-System Pharmacy (Unknown File Type)
10Offsite Document  Multinational Comparisons of Health Systems Data, 2011, 12/31/2011
 - Source: The Commonwealth Fund (Unknown File Type)
10Offsite Document  Prescription Drug Accessibility and Affordability in the United States and Abroad, 6/1/2010
 - Source: The Commonwealth Fund Adobe Acrobat PDF
10Offsite Document  National Authority for Health: France, 7/31/2009
 - Source: The Commonwealth Fund (Unknown File Type)
10Offsite Document  Institute for Quality and Efficiency in Health Care: Germany, 7/1/2009
 - Source: The Commonwealth Fund Adobe Acrobat PDF
10Offsite Document  The National Institute for Health and Clinical Excellence (NICE), 2011, 12/31/2011
 - Source: The National Institute for Health and Clinical Excellence (Unknown File Type)
10Offsite Document  National Authority for Health: France, 7/1/2009
 - Source: The Commonwealth Fund (Unknown File Type)
10Offsite Document  Prescription Drug Trends, 5/31/2011
 - Source: Kaiser Family Foundation Adobe Acrobat PDF
10Offsite Document  Lower-Than-Expected Medicare Drug Costs Reflect Decline in Overall Drug Spending and Lower Enrollment, Not Private Plans, 5/6/2011
 - Source: Center on Budget and Policy Priorities (Unknown File Type)
10Offsite Document  Consumer groups: Obama more generous to Big Pharma in trade talks, 10/24/2011
 - Source: Healthwatch (Unknown File Type)
9Briefing  BALANCING THE PROMISE AND COST OF BIOTECHNOLOGY , 9/22/2006
Biotechnology accounts for only one percent of insurers’ costs, but those costs are growing at a double digit rate. As science produces increasingly sophisticated and expensive medical products and procedures based on the manipulation of living organisms, payers will increasingly struggle with managing their use.  
9Document  Materials List, 11/7/2011
 - Source: Alliance for Health Reform (Adobe Acrobat PDF)
9Document  Source List, 11/7/2011
 - Source: Alliance for Health Reform (Adobe Acrobat PDF)
9Document  Agenda, 11/7/2011
 - Source: Alliance for Health Reform (Adobe Acrobat PDF)
9Document  Speaker Bios, 11/7/2011
 - Source: Alliance for Health Reform (Adobe Acrobat PDF)
9Briefing TranscriptTranscript, 11/7/2011
 - Source: Alliance for Health Reform (Adobe Acrobat PDF)
9Briefing TranscriptTranscript: Balancing the Cost and the Promise of Biotechnology, 9/22/2006
 (Adobe Acrobat PDF)
9Document  Steven Morgan Presentation: Well-Designed Drug Review Processes Can Improve Drug Coverage, 6/23/2006
 - Source: Centre for Health Services and Policy Research, U. of British Columbia (Adobe Acrobat PDF)
9Briefing TranscriptReviewing Prescription Drug Coverage, 6/23/2006
 - Source: Kaisernetwork.org (Adobe Acrobat PDF)
9Document  Australia's Nat'l Medicines Policy: Providing an Integrated Policy Platform for Pharmaceuticals, 6/23/2006
 - Source: Elizabeth Roughead, University of South Australia School of Pharmacy and Medical Sciences (Word Document)
9Document  Libby Roughead Presentation: Australia's National Medicines Policy, 6/23/2006
 - Source: University of South Australia (Adobe Acrobat PDF)
9Document  P. Kanavos Presentation: The European Experience in Drug Policy, Efficiency & Cost Containment, 6/23/2006
 - Source: London School of Economics (Adobe Acrobat PDF)
9Document  Tanisha Carino Presentation: The U.S. Perspective - Medicare Part D, 6/23/2006
 - Source: Avalere Health (Adobe Acrobat PDF)
9Document  Policy Approaches to Pharmaceutical Pricing and Reimbursement in European Countries, 6/23/2006
 - Source: Panos Kanavos, London School of Economics and Political Science (Word Document)
9Document  Centralized Drug Review in Australia, Canada, New Zealand and the United Kingdom, 6/23/2006
 - Source: Steven Morgan, University of British Columbia (Word Document)
9Document  Medicare's New Adventure: the Part D Drug Benefit, 3/1/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF)
9Briefing TranscriptThe Reality and Potential of Evidence-Based Medicine, 1/12/2006
 - Source: Kaisernetwork.org (Adobe Acrobat PDF)
9Briefing TranscriptWeighing the Evidence: Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005
 - Source: Alliance for Health Reform (Adobe Acrobat PDF)
9Document  Sourcelist: The Reality and Potential of Evidence-Based Medicine, 1/12/2005
 - Source: Alliance for Health Reform (Word Document)
9Document  Gail Shearer Presentation: Bringing Evidence-Based Medicine to Consumers, 1/12/2005
 - Source: Consumers Union (PowerPoint)
9Offsite Document  Q&As about the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE), 9/1/2005
 - Source: National Institute of Mental Health (Unknown File Type)
9Offsite Document  Q&As about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study , 3/23/2006
 - Source: National Institute of Mental Health (Unknown File Type)
9Offsite Document  Europe's Ailing Drug Industry, 12/28/2005
 - Source: Galen Institute (Unknown File Type)
9Offsite Document  Navigating the Medicare Part D Prescription Drug Coverage Program, 6/14/2006
 - Source: United Cerebral Palsy (Unknown File Type)
9Offsite Document  Pharmaceutical Pricing Policies and Innovation, 1/1/2006
 - Source: Organisation for Economic Co-operation and Development (Unknown File Type)
9Offsite Document  Centralized Drug Review Processes in Australia, Canada, New Zealand, and the United States, 4/1/2006
 - Source: Health Affairs (Unknown File Type)
9Offsite Document  Evidence-Based and Value-Based Formulary Guidelines, 2/1/2004
 - Source: Health Affairs (Unknown File Type)
9Offsite Document  The Efficient Use of Pharmaceuticals: Does Europe Have Any Lessons for a Medicare Drug Benefit?, 6/1/2003
 - Source: Health Affairs (Unknown File Type)
9Offsite Document  Herceptin - UK Employers Should Prepare for Rise in Healthcare Costs, 6/22/2006
 - Source: Mercer Human Resource Consulting (Unknown File Type)
9Offsite Document  Effective Health Care, 1/1/2006
 - Source: Agency for Healthcare Research and Quality (Unknown File Type)
9Offsite Document  Drug Effectiveness Review Project, 1/1/2006
 - Source: Oregon Health and Science University (Unknown File Type)
9Offsite Document  Comparative Effectiveness of Treatments for Low Bone Density (Including Osteoporosis), 1/1/2006
 - Source: Agency for Healthcare Research and Quality Adobe Acrobat PDF
9Offsite Document  FDA Drug Review Set to Unravel as Fiscal Cliff Looms, 9/10/2012
 - Source: Bloomberg (Unknown File Type)
9Offsite Document  September Sequester Surprise? Impact of the OMB Sequester Report of FDA User Fees, 9/14/2012
 - Source: Faegre Baker Daniels (Unknown File Type)
8Briefing  Private Financing and High-level Functioning: Some International Approaches to Health Reform, 4/11/2008
While the United States delivers some of the best medical care in the world, there are major inefficiencies in our system. We have high rates of medical errors, millions without health insurance coverage, and lower utilization of advanced health information technology than most western European nations. What can we learn about coverage patterns and health care costs in other countries that might help inform our choices in the U.S.? This briefing, cosponsored by The Commonwealth Fund, addressed these and related questions.  
8Briefing  Health Legislation 2007-2008: What's Possible?, 12/13/2006
Suddenly, Capitol Hill is talking about health issues again. Incoming House Speaker Nancy Pelosi promises that Democrats will roll back the prohibition against the federal government negotiating drug prices on behalf of Medicare beneficiaries. (A Kaiser Family Foundation poll released today found broad bipartisan support for this idea.) Incoming Senate Majority Leader Harry Reid says one of his three top priorities will be more funding for stem cell research. Others want to revisit the importation of prescription drugs from Canada. Additionally, the 110th Congress will consider whether to continue the State Children’s Health Insurance Program in its present form.  
8Briefing  Making Sense of Medicare's Drug Benefit: Information and Resources to Help Beneficiaries, 11/7/2005
To help understand the basics of the new Medicare prescription drug benefit, the nonpartisan Alliance for Health Reform and the Kaiser Family Foundation held a briefing especially for congressional staff, including district and state staff, but also of interest to others. Panelists were Tricia Neuman of the Kaiser Family Foundation’s Medicare Policy Project; Jack Vogelsong of Pennsylvania’s State Health Insurance and Assistance Program; Beatrice Disman of the New York Region of the Social Security Administration; and Julie Goon of the Centers for Medicare and Medicaid Services.  
8Briefing  Implementing the Medicare Drug Benefit: The Stories Ahead, 9/27/2005
Medicare beneficiaries can start signing up for prescription drug plans on November 15. Already, health plans have announced that they will be spending up to $80 million each to promote their offerings. The federal government and nonprofit groups are well into a massive effort to educate the public. But beneficiaries and those they rely on still have many questions about the program. The Alliance for Health Reform sponsored a briefing on Sept. 27 to help reporters with their coverage of the new benefit's implementation and offer story ideas. 
8Briefing  WEIGHING THE EVIDENCE: Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005
Publicly funded health programs, large employers and managed care plans all are working to learn more about how the costs and benefits of one drug compare with those of another. At the same time, these payers of health care want to make sure that their beneficiaries have access to new pharmaceuticals that offer measurable improvements over older products. What evidence gets reviewed in deciding (or recommending) whether a drug gets covered? How open to public scrutiny is the review process? Which stakeholders are most closely involved? Are decisions ever revisited or reversed? How do review methods differ among different countries?  
8Briefing  The Reality and Potential of Evidence-Based Medicine, 1/12/2005
Evidence-based medicine offers a win-win proposition: improve the quality and effectiveness of care while at the same time identifying opportunities to reduce waste of valuable health care resources. But what evidence should employers, health care providers and consumers pay attention to? And how should this information be disseminated to those who need it? 
8Document  Using Clinical Evidenceto Manage Pharmacy Benefits: Experiences of Six States, 3/1/2007
 - Source: The Commonwealth Fund (Adobe Acrobat PDF)
8Document  Robinson Presentation: Balancing the Promise and Cost of Biotechnology, 9/22/2006
 (Adobe Acrobat PDF)
8Document  Tunis Presentation: Balancing the Promise and Cost of Biotechnology, 9/22/2006
 (Adobe Acrobat PDF)
8Document  Sourcelist: Reviewing Prescription Drug Coverage, 6/23/2006
 - Source: Alliance for Health Reform (Word Document)
8Document  Tricia Neuman Presentation: The Medicare Prescription Drug Benefit, 11/7/2005
 - Source: Kaiser Family Foundation (Adobe Acrobat PDF)
8Briefing TranscriptMaking Sense of Medicare's Drug Benefit, 11/7/2005
 - Source: Kaisernetwork.org (Adobe Acrobat PDF)
8Document  Sourcelist: Weighing the Evidence- Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005
 - Source: Alliance for Health Reform (Word Document)
8Offsite Document  Principles for Govt-Supported Health Outcomes Research on Medical Technologies & Services, 1/1/2006
 - Source: PhRMA (Unknown File Type)
8Offsite Document  Strengthen Medicare: End Drug Company Price Setting, 5/28/2013
 - Source: Health Affairs Blog (Unknown File Type)
7Document  Medication Errors Injure 1.5 Million People and Costs Billions of Dollars Annually, 7/20/2008
 - Source: Institute of Medicine (Adobe Acrobat PDF)
7Document  Letter to Baucus, 5/22/2008
 - Source: Various Drugstore Chains (Adobe Acrobat PDF)
7Document  Medicare Part D Fact Sheet, 10/29/2007
 - Source: Kaiser Family Foundation (Adobe Acrobat PDF)
7Document  Tracking Medicare Health and Prescription Drug Plans - Monthly Report for September 2007, 10/10/2007
 - Source: Kaiser Family Foundation and Mathematica Policy Research, Inc. (Adobe Acrobat PDF)
7Document  2007 State of the Union Policy Initiatives: Affordable, Accessible, And Flexible Health Covera, 1/1/2007
 - Source: The White House (Word Document)
7Document  Comparitive Effectiveness Forum: Executive Summary, 11/30/2006
 - Source: The Health Industry Forum (Adobe Acrobat PDF)
7Document  Drug Money, 6/16/2006
 - Source: Christopher Gallen, Canadian Business (Word Document)
7Document  CMS Sets $500 Threshold for Specialty Tiers, 4/1/2006
 - Source: Medicare Drug Reimbursement Guide  (Adobe Acrobat PDF)
7Document  418 Biotechnology Medicines in Testing Promise to Bolster the Arsenal Against Disease, 1/1/2006
 - Source: Pharmaceutical Research and Manufacturers Association (PhRMA) (Adobe Acrobat PDF)
7Document  Australia's Centralized Cost-Effectiveness Requirement for Pharmaceuticals, 1/1/2006
 - Source: IMS Consulting (Adobe Acrobat PDF)
7Document  As biotech drug prices rise, U.S. hunts for solution, 12/28/2005
 - Source: Geeta Anand, The Wall Street Journal (Word Document)
7Document  Julie Goon Presentation: CMS Information and Resources for the Medicare Drug Benefit, 11/7/2005
 - Source: CMS (Adobe Acrobat PDF)
7Document  Sourcelist: Making Sense of Medicare's Drug Benefit, 11/7/2005
 - Source: Alliance for Health Reform (Word Document)
7Document  Mark Benoff Presentation: Implementing the Medicare Drug Benefit, 9/27/2005
 - Source: Cambridge Pharma Consultancy (Adobe Acrobat PDF)
7Document  Sourcelist: Implementing the Medicare Drug Benefit, 9/27/2005
 - Source: Alliance for Health Reform (Word Document)
7Briefing TranscriptImplementing the Medicare Drug Benefit, 9/27/2005
 - Source: Kaisernetwork.org (Adobe Acrobat PDF)
7Document  2005 International Symposium on Health Care Policy: Descriptions of Health Care Systems, 1/1/2005
 - Source: The Commonwealth Fund (Adobe Acrobat PDF)
7Offsite Document  Frist Highlights AHRQ's Efforts to Improve Quality of Health Care, 2/9/2006
 - Source: Bill Frist, M.D. United States Senator, Tennessee (Unknown File Type)
7Offsite Document  Consumer Reports Medical Website Gives Evidence & Treatment Ratings to Make Informed Decisions, 5/17/2005
 - Source: Consumer Reports (Unknown File Type)
7Offsite Document  Developing a Center for Comparative Effectiveness Information, 11/1/2006
 - Source: Health Affairs (Unknown File Type)
7Offsite Document  Consumer Reports: Best Buy Drugs, 4/27/2007
 - Source: Consumer Report (Unknown File Type)
7Offsite Document  Drug Effectiveness Review, 4/27/2007
 - Source: Oregon Health Science University (Unknown File Type)
7Offsite Document  Medicare Part D: Assessing the Impact for Beneficiaries Without Prev Drug Coverage and Dual Eli, 9/1/2007
 - Source: PhRMA Adobe Acrobat PDF
7Offsite Document  Medicare Part D Chartpack, 11/7/2007
 - Source: Kaiser Family Foundation (Unknown File Type)
7Offsite Document  Medicare Part D 2008 Data Spotlights, 11/7/2007
 - Source: Kaiser Family Foundation (Unknown File Type)
7Offsite Document  Minnesota Mandates E-Prescribing, 6/3/2008
 - Source: Health Data Management (Unknown File Type)
6Briefing  Prospects for Health Care: Where Will New Congressional Leadership Take Us?, 12/8/2006
Come January, we can expect to see some new approaches to health legislation. Sen. Harry Reid, incoming Senate majority leader, says one of his top three priorities will be more funding for stem cell research. House Speaker-to-be Nancy Pelosi wants a vote early on to roll back the prohibition against the federal government negotiating prescription drug prices for Medicare beneficiaries. And these are just two of the health issues likely to be debated in the new Congress. The White House too will have a definite voice in the debates to come. 
6Document  The Power of Partnerships: Lessons from Outreach for the Part D Low-Income Subsidy Program, 9/1/2007
 - Source: Kaiser Permanente (Adobe Acrobat PDF)
6Document  AHIP Statement on Medicare Part D, 1/1/2007
 - Source: America's Health Insurance Plans (Adobe Acrobat PDF)
6Briefing TranscriptWhat Other Nations Can Teach Us About A More Patient Centered Health Care System, Part I, 11/4/2006
 - Source: Kaisernetwork.org (Adobe Acrobat PDF)
6Briefing TranscriptWhat Other Nations Can Teach Us About A More Patient Centered Health Care System, Part II, 11/4/2006
 - Source: Alliance for Health Reform  (Adobe Acrobat PDF)
6Briefing TranscriptWhat Other Nations Can Teach Us About A More Patient Centered Health Care System, Part III, 11/4/2006
 - Source: Alliance for Health Reform  (Adobe Acrobat PDF)
6Document  Health Care Opinion Leaders Survey: Medicare Part D, 7/6/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF)
6Document  New Study Captures Variations Across Medicare Drug Plans, 4/11/2006
 - Source: Kaiser Family Foundation  (Word Document)
6Document  The U.S. Health Care Divide: Disparities in Primary Care Experiences by Income, 4/1/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF)
6Document  Mirror, Mirror on the Wall: Update on the Quality of American Health Care , 4/1/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF)
6Document  The Rise and Role of Specialty Pharmacies, 10/1/2005
 - Source: David Suchanek, Biotechnology Healthcare (Adobe Acrobat PDF)
6Document  Aetna Letter: Health Savings Accounts - Exceptions for Preventive Prescription Drugs, 5/25/2005
 - Source: Aetna (Adobe Acrobat PDF)
6Offsite Document  Taking the Pulse of Health Care Systems: Experiences of Patients in Six Countries, 11/3/2005
 - Source: Health Affairs (Unknown File Type)
6Offsite Document  Squeezed: Why Rising Exposure to Health Care Costs Threatens the Health and Financial Well-Bein, 10/1/2006
 - Source: The Commonwealth Fund (Unknown File Type)
6Offsite Document  Average Medicare Prescription Drug Premiums to Rise 21%, 10/5/2007
 - Source: Avalere Health (Unknown File Type)
6Offsite Document  Electronic Prescribing: Becoming a Mainstream Practice, 6/10/2008
 - Source: eHealth Initiative and Center for improving Medication Management Adobe Acrobat PDF
6Offsite Document  E-prescribing Campaign Aims at Patients to Reach Doctors, 6/2/2008
 - Source: American Medical News (Unknown File Type)
6Offsite Document  OMB Report Pursuat to the Sequestration Transparency Act of 2012 (P.L. 112-155), 9/1/2012
 - Source: Office of Management and Budget Adobe Acrobat PDF
5Briefing  Health Policy Ahead: Conversation with Congressional Staff, 12/5/2014
Top congressional health care staff members will meet with reporters December 5 to discuss what you need to know to cover health care policy in the lame duck session and in 2015. 
5Document  Marsha Gold Presentation: What We Know From Analyzing Public Data Files, 5/19/2006
 - Source: Mathematica Policy Research, Inc.  (Adobe Acrobat PDF)
5Offsite Document  Details on Medicare Prescription Drug Deal Remain Murky, 7/13/2009
 - Source: Commonwealth Fund  (Unknown File Type)
5Offsite Document  American College of Cardiology Supports E-Prescription Mandate, 6/3/2008
 - Source: iHealth Beat (Unknown File Type)
5Offsite Document  Candidates Issue Index, 5/13/2008
 - Source: The Brookings Institution (Unknown File Type)

 

Related Links

Toolkit: Emergency Preparedness in the U.S.: The Ebola Threat


Is the U.S. prepared for a potential virulent pandemic? This new Alliance toolkit examines public health infrastructure, funding and policy levers that deal with these kinds of health crises in America.

Read More 

Copyright 1997-2015 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      info@allhealth.org      Sitemap